Jan 19, 2016 Cerecor Announces Publication Describing Antidepressant Activity of CERC-301 in Preclinical Model
Dec 21, 2015 Cerecor Inc. Names Uli Hacksell, Chairman of Cerecor and Former CEO of ACADIA, as President and CEO
Dec 11, 2015 Publication Reports Human Brain Penetration and Target Engagement of Cerecor’s Oral Kappa Opioid Receptor Antagonist, CERC-501
